MassMutual Private Wealth & Trust’s Cytokinetics CYTK Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.8K	Sell	376 -72	-16%	-$5.49K	﹤0.01%	991
2026 Q2	$38.2K	Buy	448 +5	+1%	+$359	﹤0.01%	878
2026 Q1	$29.2K	Buy	443 +6	+1%	+$381	﹤0.01%	954
2025 Q4	$27.8K	Buy	437 +100	+30%	+$6.22K	﹤0.01%	990
2025 Q3	$18.5K	Sell	337 -14	-4%	-$577	﹤0.01%	1146
2025 Q2	$11.6K	Buy	351 +159	+83%	+$5.53K	﹤0.01%	1301
2025 Q1	$7.72K	Buy	192 +76	+66%	+$3.49K	﹤0.01%	1397
2024 Q4	$5.46K	Hold	116	–	–	﹤0.01%	1502
2024 Q3	$6.13K	Hold	116	–	–	﹤0.01%	1301
2024 Q2	$6.29K	Sell	116 -5	-4%	-$302	﹤0.01%	1244
2024 Q1	$8.48K	Buy	121 +5	+4%	+$387	﹤0.01%	1089
2023 Q4	$9.69K	Sell	116 -8	-6%	-$290	﹤0.01%	1034
2023 Q3	$3.65K	Buy	124 +92	+288%	+$3.06K	﹤0.01%	1344
2023 Q2	$1.04K	Sell	32 -23	-42%	-$851	﹤0.01%	1644
2023 Q1	$1.94K	Sell	55 -56	-50%	-$2.29K	﹤0.01%	1430
2022 Q4	$5K	Hold	111	–	–	﹤0.01%	979
2022 Q3	$5K	Buy	111 +8	+8%	+$385	﹤0.01%	936
2022 Q2	$4K	Buy	103 +79	+329%	+$3.18K	﹤0.01%	949
2022 Q1	$1K	Buy	+24	New	+$853	﹤0.01%	1299

Other funds holding CYTK

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return

BCG

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

MassMutual Private Wealth & Trust's CYTK Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Cytokinetics (CYTK) stake by 16% in Q3 2026, selling an estimated $5.49K and leaving 376 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

MassMutual Private Wealth & Trust first reported a position in CYTK in Q1 2022 and has held it in 19 quarters since. The position peaked at $38.2K in Q2 2026. 10 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

MassMutual Private Wealth & Trust held 376 shares of Cytokinetics worth $24.8K as of Q3 2026.
MassMutual Private Wealth & Trust sold 72 Cytokinetics shares in Q3 2026, an estimated $5.49K.
Cytokinetics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #991 holding.
MassMutual Private Wealth & Trust first reported a position in Cytokinetics in Q1 2022 and has held it in 19 quarters since.
MassMutual Private Wealth & Trust's Cytokinetics position peaked at $38.2K in Q2 2026.
10 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.